ÂÜÀòÂÒÂ×

Suk Joong Lee has a strong research background with extensive work experience in various positions. Suk Joong began their career as a Postdoctoral Research Associate at the University of Illinois at Urbana-Champaign, where they worked with Prof. Martin D. Burke and Prof. Peter Beak. During their time at the university, they focused on the design and development of general polyene methodology, making significant contributions to the synthesis of polyene natural products. Their work led to the transfer of synthetic routes to industry for commercialization.

In 2010, Suk Joong Lee joined Trius Therapeutics INC, a Cubist Company, as a Research Scientist I. Suk Joong was later promoted to Research Scientist II. Their work at Trius Therapeutics involved the discovery and development of a new class of broad-spectrum dual-targeting antibacterial agents known as Tricyclic GyrB/ParE (TriBE) inhibitors. Suk Joong played a crucial role in designing efficient synthetic routes and improving the formulation of lead compounds in the TriBE series. Some of their accomplishments include developing an asymmetric route for producing chiral diamine building blocks and discovering diammonium phosphate prodrugs that significantly improved solubility and stability.

Since 2014, Suk Joong Lee has been working at Epigen Biosciences, Inc. Suk Joong started as a Research Scientist and gradually advanced to Principal Scientist and currently holds the position of Senior Principal Scientist. Their work at Epigen Biosciences involves leading and directing scientific research projects. Although no specific details are provided about their roles and responsibilities at the company, it can be inferred that they continue to contribute to the advancement of scientific knowledge and innovation in the field.

Overall, Suk Joong Lee has a successful track record in research and has made significant contributions to the development of novel antibacterial agents and the synthesis of natural products. Their expertise in the design and optimization of synthetic routes has led to the commercialization of key compounds and methodologies.

Suk Joong Lee completed their Bachelor's Degree in Chemistry at Chungnam National University in Korea from 1988 to 1992. Suk Joong then pursued a Master's Degree in Organic Chemistry at the same university from 1995 to 1997. Later, from 1997 to 2001, they earned their Doctor of Philosophy (Ph.D.) in Synthetic Organic Chemistry also from Chungnam National University.